Wallachbeth Capital Announces Purchase And Sale Of Lixte Biotechnology Holdings, Inc. (Nasdaq: Lixt)
Acquiring Company
WallachBeth Capital
Acquired Company
Nomad Power Solutions, Inc.
Description
WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced that LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage drug discovery company developing pharmacologically active drugs for use in cancer treatment, has entered into definitive agreements for the purchase and sale of 2,900,000 shares of LIXTE's common stock at a purchase price of $2.00 per share in a registered direct offering. The gross proceeds to LIXTE from this offering are expected to be approximately $5.8 million before deducting the placement agents' fees and other offering expenses.
Quick answer
WallachBeth Capital is acquiring Nomad Power Solutions, Inc., announced April 13, 2022.
- Who acquired Nomad Power Solutions, Inc?
- WallachBeth Capital agreed to acquire Nomad Power Solutions, Inc. on April 13, 2022.
- How much did WallachBeth Capital pay for Nomad Power Solutions, Inc?
- The deal value was not disclosed.
- What does WallachBeth Capital do?
- WallachBeth Capital offers a robust range of capital markets and investment banking services to the healthcare community, connecting corporate clients with leading institutions, creating value for both issuers and..
- Where are WallachBeth Capital and Nomad Power Solutions, Inc. based?
- Nomad Power Solutions, Inc. is based in Boca Raton, Florida, United States.
Source: Fundz verified event record.
Other recent acquisitions in Professional Services and Financial Services
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Wallachbeth Capital Announces Purchase And Sale Of Lixte Biotechnology Holdings, Inc. (Nasdaq: Lixt) (April 13, 2022)
- Regeneron To Acquire Checkmate Pharmaceuticals And Its Investigational Immune Activator For Potential Use In Multiple Tumor Types (April 19, 2022)
- Aprea Therapeutics Announces Acquisition Of Atrin Pharmaceuticals Inc. And Reports First Quarter 2022 Financial Results (May 16, 2022)
- Pfizer To Acquire Biohaven Pharmaceuticals (May 10, 2022)
- Consegna Pharma Acquires Fathom Pharma To Strengthen Initiatives That Address The Opioid Crisis (April 19, 2022)
- Stratos Wealth Enterprises Acquires Minority Equity Stake In Boston-Based Wealth Management Firm With $350 Million In Aum, $350M (April 12, 2022)
Who to call at WallachBeth Capital, and when
When WallachBeth Capital changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day WallachBeth Capital raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at WallachBeth Capital, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at WallachBeth Capital. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment WallachBeth Capital makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Nomad Power Solutions, Inc.?
Nomad Power Solutions, Inc. was acquired by WallachBeth Capital. The deal was reported on April 13, 2022. WallachBeth Capital is privately held and operates in Professional Services.
When did WallachBeth Capital acquire Nomad Power Solutions, Inc.?
WallachBeth Capital's acquisition of Nomad Power Solutions, Inc. was reported on April 13, 2022. WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced that LIXTE Biotechnology Holdings, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Nomad Power Solutions, Inc. do?
LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), is a clinical-stage pharmaceutical company focused on new targets for cancer drug development and developing and commercializing cancer therapies. It is publicly traded (NMAD), operating in Information Technology, and is based in Boca Raton.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.